BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8139785)

  • 21. Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia.
    Agorastos T; Vaitsi V; Paschopoulos M; Vakiani A; Zournatzi-Koiou V; Saravelos H; Kostopoulou E; Constantinidis T; Dinas K; Vavilis D; Lolis D; Bontis J
    Maturitas; 2004 Jun; 48(2):125-32. PubMed ID: 15172086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
    Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protocol with GnRH-antagonist and ovulation trigger with GnRH-agonist in risk patients--a reliable method of prophylactic of OHSS].
    Kovachev E
    Akush Ginekol (Sofiia); 2008; 47(4):16-9. PubMed ID: 19227761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic adhesion and gonadotropin-releasing hormone analogue: effects of triptorelin acetate depot on coagulation and fibrinolytic activities.
    Di Nardo MA; Annunziata ML; Ammirabile M; Di Minno MN; Ruocco AL; De Falco M; Di Lieto A
    Reprod Sci; 2012 Jun; 19(6):615-22. PubMed ID: 22344729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
    Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
    JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
    Zhou H; Cao D; Yang J; Shen K; Lang J
    Int J Gynecol Cancer; 2017 Jul; 27(6):1178-1182. PubMed ID: 28562472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different effects of agonistic vs. antagonistic gnrh-analogues (triptorelin vs. cetrorelix) on bone modeling and remodeling in peripubertal female rats.
    Roth CL; Neu C; Jarry H; Schoenau E
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):451-6. PubMed ID: 16151979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endometriosis].
    Osuga Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():112-5. PubMed ID: 16689294
    [No Abstract]   [Full Text] [Related]  

  • 34. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal management of endometrial hyperplasia.
    Marsden DE; Hacker NF
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):393-405. PubMed ID: 11476561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation.
    Gründker C; Günthert AR; Millar RP; Emons G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1427-30. PubMed ID: 11889221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current possibilities of examination and preservative treatment in endometrial hyperplasia].
    Kołodziejczak M; Knapp P; Kuźmicki M; Knapp P
    Ginekol Pol; 2011 Jul; 82(7):514-9. PubMed ID: 21913429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of a long-acting and short-acting GnRH analog in combination with gonadotropins in in vitro fertilization under various indications].
    Schmutzler RK; Reichert C; Diedrich K; Wildt L; Diedrich C; van der Ven H; Al-Hasani S; Krebs D
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():85-90. PubMed ID: 2522902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptorelin in the management of prostate cancer.
    Ploussard G; Mongiat-Artus P
    Future Oncol; 2013 Jan; 9(1):93-102. PubMed ID: 23252566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.